Aprepitant Effects in Intravenous Heroin Dependence

NCT01527994 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Opioid Dependence

Interventions

DRUG: Aprepitant
DRUG: Placebo pill

Sponsor

NYU Langone Health

Collaborators

[object Object]